Medicines Company hires Parkin as senior VP of international operations

Glyn R. Parkin has joined the Medicines Company as senior vice president of international operations responsible for the design, implementation and leadership of the international organization.

He will be responsible for the establishment of functioning, capable organizations and business operations in new territories, and then transitioning the operations to the current business unit structure of the organization, according to the Parsippany, N.J.-based company.

Parkin was with Eli Lilly for more than 25 years, where he served as executive director marketing and oversaw European operations of the Lilly Europe executive leadership team as well as marketing, Medicines Company said. He previously held U.K. sales and marketing leadership positions, and spent eight years in Indiana ,where he served as global marketing director for Lilly Diabetes Care and led their neuroscience division.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.